tag:blogger.com,1999:blog-3237322661993424035.post1635492920043138655..comments2023-09-07T01:35:44.194-07:00Comments on Endocrine Journal Club: UKPDS Follow-up NEJMUnknownnoreply@blogger.comBlogger1125tag:blogger.com,1999:blog-3237322661993424035.post-14998731990190183732008-11-19T13:05:00.000-08:002008-11-19T13:05:00.000-08:00From table 2: It's interesting that with metformin...From table 2: It's interesting that with metformin there is no significant risk reduction in microvascular disease (0.60-1.17), but there is in the sulfonylurea-insulin group (0.64-0.89). All other outcomes are similar with respect to significance. Does it follow then that the sulfonylurea/insulin class is the better class?MikeLhttps://www.blogger.com/profile/03414912640886130408noreply@blogger.com